Form 4: Singular Genomics CEO Andrew Spaventa Reports Stock Transactions
SEC Form 4 Filing
CEO Andrew Spaventa reports the acquisition and disposal of Singular Genomics Systems, Inc. stock, including transactions related to restricted stock units and a gift transfer.
Summary
- On September 15, 2024, Andrew Spaventa, CEO of Singular Genomics Systems, Inc., reported transactions involving the company's common stock.
- These transactions included the acquisition of 487 shares through the settlement of vested Restricted Stock Units (RSUs).
- Spaventa also disposed of 175 shares at $12.381 to cover tax obligations related to the vesting of RSUs.
- Additionally, 312 shares were gifted to The Andrew K. Spaventa Living Trust dated April 9, 2014.
- Following these transactions, Spaventa directly owns 637 shares and indirectly owns 140,275 shares through The Andrew K. Spaventa Living Trust and 85 shares through Axon Holdings, LLC.
- The reported transactions reflect adjustments for a 1-for-30 reverse stock split that occurred on June 26, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
- The transactions reported are typical for executives receiving stock-based compensation, such as RSUs, and selling shares to cover tax obligations.
- Reverse stock splits are often undertaken by companies to increase their stock price and maintain listing requirements, a strategy employed by many companies in similar situations.
Related Party Transactions
- The gift of 312 shares to The Andrew K. Spaventa Living Trust dated April 9, 2014, is a related party transaction.
Stakeholder Impact
- The transactions may provide insights to shareholders regarding management's actions, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| April 9, 2014 | Date of The Andrew K. Spaventa Living Trust |
| March 15, 2023 | RSUs vest in 16 equal quarterly installments over four years measured from this date. |
| June 26, 2024 | Date of the 1-for-30 reverse stock split. |
| September 15, 2024 | Date of reported stock transactions. |
| September 17, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.